Literature DB >> 24739614

Anti-citrullinated protein antibody-positive rheumatoid arthritis associated with RS3PE syndrome-like symptoms and an elevated serum vascular endothelial growth factor level in a patient with myasthenia gravis.

Yoshiro Horai1, Mai Honda, Ayako Nishino, Yoshikazu Nakashima, Takahisa Suzuki, Shin-Ya Kawashiri, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Masakatsu Motomura, Tomoki Origuchi, Atsushi Kawakami.   

Abstract

A 73-year-old man with a history of myasthenia gravis (MG) was diagnosed with rheumatoid arthritis (RA) based on a history of polyarthritis and positivity for anti-citrullinated protein antibodies (ACPA). He presented with a high level of serum vascular endothelial growth factor (VEGF) and RS3PE syndrome-like pitting edema in the extremities, which improved following treatment with low-dose prednisolone. This is an interesting case of ACPA-positive RA associated with RS3PE syndrome-like pitting edema and a high VEGF level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739614     DOI: 10.2169/internalmedicine.53.1897

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  RS3PE: Clinical and Research Development.

Authors:  Hongbin Li; Roy D Altman; Qingping Yao
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

2.  Relationship between PI3K pathway and angiogenesis in CIA rat synovium.

Authors:  Lin Zou; Guichun Zhang; Lifeng Liu; Chen Chen; Xuecheng Cao; Jinfang Cai
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 3.  Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.

Authors:  Riccardo Bixio; Davide Bertelle; Francesca Pistillo; Elisa Pedrollo; Antonio Carletto; Maurizio Rossini; Ombretta Viapiana
Journal:  Clin Rheumatol       Date:  2022-01-14       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.